Oaktree Acquisition Corp. III Life Sciences (OACCU) Accounts Payables (2024 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Accounts Payables came in at $751463.0 in Q1 2026, up 89.91% YoY from $395686.0 in Q1 2025, and up 49.7% on a QoQ basis from $501968.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Accounts Payables (2024 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 3 years of Accounts Payables data on file, last reported at $751463.0 in Q1 2026.
- Quarterly Accounts Payables rose 89.91% year-over-year to $751463.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $751463.0 (up 89.91% YoY) and the FY2025 annual result came in at $501968.0, down 6.26% from the prior year.
- Accounts Payables improved to $751463.0 in Q1 2026, from $501968.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $751463.0 in Q1 2026 to a low of $381554.0 in Q2 2025.
- A 3-year average of $496715.5 and a median of $458037.5 in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2025 — Accounts Payables retreated 6.26% — and 2026, when it surged 89.91%.
- Tracing OACCU's Accounts Payables over 3 years: stood at $535515.0 in 2024, then retreated by 6.26% to $501968.0 in 2025, then soared by 49.7% to $751463.0 in 2026.
- The last three Accounts Payables figures came in at $751463.0 (Q1 2026), $501968.0 (Q4 2025), and $414107.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 782,152.00 |
| Mar 31, 2026 | 751,463.00 |
| Dec 31, 2025 | 501,968.00 |
| Sep 30, 2025 | 414,107.00 |
| Jun 30, 2025 | 381,554.00 |
| Mar 31, 2025 | 395,686.00 |
| Dec 31, 2024 | 535,515.00 |